Author

Hun Ju Lee

The University of Texas MD Anderson Cancer CenterORCID 0000-0001-7219-5562Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Christopher R. FlowersiD· 2 shared Jason R. WestiniD· 2 shared Loretta J. NastoupiliD· 2 shared Luis FayadiD· 2 shared Paolo StratiiD· 2 shared Sattva Swarup NeelapuiD· 2 shared Swaminathan P. IyeriD· 2 shared Aneela Syeda AbediniD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christopher R. FlowersORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBlood Cancer DiscoveryPeer-reviewedJun 24, 2026

A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma

Haopeng Yang, Kotaro Arita, Kevin Bowman…·Michael R. Green

The paper establishes a PDX repository of large B-cell lymphoma models capturing clinical and molecular diversity, including post-CART19 progression cases.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

GeneticsbioRxivPreprintSep 28, 2021

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum…·Koichi Takahashi

This study finds that clonal hematopoiesis mutations, particularly in DNMT3A, TET2, and ASXL1, are linked to increased toxicity in patients undergoing anti-CD19 CAR T-cell therapy for large B-cell lymphoma.

DOI 10.1101/2021.09.28.461858

humanwhole-exome sequencing

𝕏 PostBluesky